Senti Biosciences Sells Certain Assets to Celadon Partners
August 14, 2023
Cooley advised Senti Biosciences, a biotechnology company, on its sale of certain assets – including its manufacturing facility and chemistry, manufacturing, and controls capabilities – to Celadon Partners.